CN101795694B - 注射剂、注射液和注射用试剂盒制剂 - Google Patents
注射剂、注射液和注射用试剂盒制剂 Download PDFInfo
- Publication number
- CN101795694B CN101795694B CN2008801053808A CN200880105380A CN101795694B CN 101795694 B CN101795694 B CN 101795694B CN 2008801053808 A CN2008801053808 A CN 2008801053808A CN 200880105380 A CN200880105380 A CN 200880105380A CN 101795694 B CN101795694 B CN 101795694B
- Authority
- CN
- China
- Prior art keywords
- injection
- hydrochloride
- antibiotic
- malignant tumor
- anthracene nucleus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7028—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
- A61K31/7034—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
- A61K31/704—Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
- A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Dermatology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
Description
实施例·比较例 | 助溶剂 | 配合量 | 溶解性 |
实施例1 | 烟酰胺 | 250mg | 30秒以内溶解 |
实施例2 | 异烟酰胺 | 250mg | 60秒以内溶解 |
实施例3 | 龙胆酸乙醇胺 | 100mg | 30秒以内溶解 |
比较例1 | 烟酸 | 60mg | 10分钟以内不溶解 |
比较例2 | N,N’-二甲基乙酰胺 | 300mg | 10分钟以内不溶解 |
比较例3 | 对羟基苯甲酸甲酯 | 2mg | 10分钟以内不溶解 |
比较例4 | 脲 | 50mg | 10分钟以内不溶解 |
比较例5 | 聚山梨酯20 | 80mg | 10分钟以内不溶解 |
比较例6 | 聚乙二醇4000 | 120mg | 10分钟以内不溶解 |
比较例7 | 聚氧乙烯(160)聚氧丙烯(30) | 10mg | 10分钟以内不溶解 |
比较例8 | 柠檬酸 | 0.4mg | 10分钟以内不溶解 |
比较例9 | 乙二胺四乙酸钠 | 1.7mg | 10分钟以内不溶解 |
比较例15(对照品) | 实施例9(处方1) | 实施例10(处方2) | 实施例11(处方3) | |
盐酸吡柔比星 | 20mg(效价) | 20mg(效价) | 20mg(效价) | 20mg(效价) |
烟酰胺 | - | 15mg | 20mg | 80mg |
乳糖 | 180mg | 180mg | 180mg | 180mg |
氢氧化钠 | 适量 | 适量 | 适量 | 适量 |
注射用蒸留水 | 使总量为3mL的量 | 使总量为3mL的量 | 使总量为3mL的量 | 使总量为3mL的量 |
溶解时间 | 10分钟以上 | 8分钟10秒 | 10秒 | 5秒 |
实施例·比较例 | 烟酰胺添加量(mg) | 溶解时间 |
比较例17 | 无添加 | 10分钟以上 |
实施例13 | 8 | 120秒 |
实施例14 | 15 | 120秒 |
实施例15 | 20 | 60秒 |
实施例16 | 80 | 30秒以内 |
实施例17 | 250 | 30秒以内 |
Claims (5)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2007228516 | 2007-09-04 | ||
JP228516/2007 | 2007-09-04 | ||
PCT/JP2008/065865 WO2009031577A1 (ja) | 2007-09-04 | 2008-09-03 | 注射剤、注射液および注射用キット製剤 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN101795694A CN101795694A (zh) | 2010-08-04 |
CN101795694B true CN101795694B (zh) | 2012-10-10 |
Family
ID=40428891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN2008801053808A Active CN101795694B (zh) | 2007-09-04 | 2008-09-03 | 注射剂、注射液和注射用试剂盒制剂 |
Country Status (10)
Country | Link |
---|---|
US (1) | US8227430B2 (zh) |
EP (1) | EP2184066B1 (zh) |
JP (1) | JP4456177B2 (zh) |
KR (1) | KR101511398B1 (zh) |
CN (1) | CN101795694B (zh) |
BR (1) | BRPI0816364B8 (zh) |
ES (1) | ES2439497T3 (zh) |
HK (1) | HK1142820A1 (zh) |
MX (1) | MX2010001263A (zh) |
WO (1) | WO2009031577A1 (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102614118B (zh) * | 2012-03-15 | 2014-04-30 | 北京协和药厂 | 注射用盐酸表柔比星制剂的制备方法及制剂 |
WO2013154045A1 (ja) * | 2012-04-09 | 2013-10-17 | 日本マイクロバイオファーマ株式会社 | 注射剤用組成物 |
JP7001454B2 (ja) | 2017-12-18 | 2022-01-19 | 日本化薬株式会社 | ホスアプレピタントを含有する医薬製剤 |
LU101511B1 (en) * | 2019-12-02 | 2021-06-04 | Herrera Arturo Solis | (S)-3-[1-Methylpyrrolidin-2-yl]pyridine, analogues thereof, precursors thereof, or its derivatives, for the use as a pharmaceutical in form of a parenteral administration and a process for the preparation of an injectable substance |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB485569A (en) * | 1936-11-17 | 1938-05-17 | Ig Farbenindustrie Ag | Process for the manufacture of stable solutions of the polyoxyalkylisoalloxazines |
JPS58105917A (ja) * | 1981-12-21 | 1983-06-24 | Toa Eiyou Kagaku Kogyo Kk | イソソルビド硝酸エステル溶液 |
GB8426672D0 (en) * | 1984-10-22 | 1984-11-28 | Erba Farmitalia | Pharmaceutical compositions |
EP0438183B1 (en) * | 1986-12-05 | 1995-11-08 | PHARMACIA S.p.A. | Injectable ready-to-use solutions containing an antitumor anthracycline glycoside |
US4875311A (en) * | 1988-04-20 | 1989-10-24 | Sun Room Designs, Inc. | Beam construction |
JP2919112B2 (ja) | 1991-05-13 | 1999-07-12 | 武田薬品工業株式会社 | セファロスポリン注射剤およびその製造法 |
JP2915252B2 (ja) * | 1993-06-30 | 1999-07-05 | 明治製菓株式会社 | 溶解性が改善された製剤の製造法 |
TW280770B (zh) * | 1993-10-15 | 1996-07-11 | Takeda Pharm Industry Co Ltd | |
JPH09124503A (ja) | 1995-10-27 | 1997-05-13 | L T T Kenkyusho:Kk | アミチアマイシン類の注射用の抗菌性組成物 |
JP2000212088A (ja) * | 1999-01-27 | 2000-08-02 | Kobayashi Kako Kk | 難溶性抗ウイルス剤の水溶液 |
KR100405161B1 (ko) | 2000-12-14 | 2003-11-12 | 신풍제약주식회사 | 록소프로펜 함유 근육주사제 조성물 |
US6881726B2 (en) * | 2001-12-24 | 2005-04-19 | Dow Pharmaceutical Sciences | Aqueous compositions containing metronidazole |
JP2003261449A (ja) * | 2002-03-05 | 2003-09-16 | Nisshin Oillio Ltd | ファモチジン含有水性注射剤およびその製造法 |
JP2004010479A (ja) * | 2002-06-03 | 2004-01-15 | Japan Science & Technology Corp | ブロック共重合体とアンスラサイクリン系抗癌剤を含む新規固型製剤及びその製造法 |
JP2004051526A (ja) | 2002-07-18 | 2004-02-19 | Nippon Shokubai Co Ltd | 多価フェノールの製造方法 |
EP1695973A1 (en) * | 2005-02-24 | 2006-08-30 | Neuro3D | Ocaperidone salt and pharmaceutical compositions containing the same |
-
2008
- 2008-09-03 MX MX2010001263A patent/MX2010001263A/es active IP Right Grant
- 2008-09-03 KR KR1020107004492A patent/KR101511398B1/ko active IP Right Grant
- 2008-09-03 BR BRPI0816364A patent/BRPI0816364B8/pt not_active IP Right Cessation
- 2008-09-03 ES ES08829253.7T patent/ES2439497T3/es active Active
- 2008-09-03 CN CN2008801053808A patent/CN101795694B/zh active Active
- 2008-09-03 WO PCT/JP2008/065865 patent/WO2009031577A1/ja active Application Filing
- 2008-09-03 JP JP2009531260A patent/JP4456177B2/ja active Active
- 2008-09-03 US US12/676,291 patent/US8227430B2/en active Active
- 2008-09-03 EP EP08829253.7A patent/EP2184066B1/en active Active
-
2010
- 2010-09-30 HK HK10109375.4A patent/HK1142820A1/xx unknown
Also Published As
Publication number | Publication date |
---|---|
BRPI0816364B8 (pt) | 2021-05-25 |
EP2184066A1 (en) | 2010-05-12 |
WO2009031577A1 (ja) | 2009-03-12 |
US8227430B2 (en) | 2012-07-24 |
HK1142820A1 (en) | 2010-12-17 |
US20100173862A1 (en) | 2010-07-08 |
BRPI0816364A2 (pt) | 2015-09-29 |
CN101795694A (zh) | 2010-08-04 |
EP2184066A4 (en) | 2012-08-01 |
EP2184066B1 (en) | 2013-11-06 |
KR20100051694A (ko) | 2010-05-17 |
BRPI0816364B1 (pt) | 2020-10-13 |
ES2439497T3 (es) | 2014-01-23 |
JPWO2009031577A1 (ja) | 2010-12-16 |
MX2010001263A (es) | 2010-10-04 |
KR101511398B1 (ko) | 2015-04-24 |
JP4456177B2 (ja) | 2010-04-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100396276C (zh) | 依普西龙组合物 | |
US8871253B2 (en) | Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt | |
CN101785861A (zh) | 用于药理活性化合物的可控释放的可注射组合物 | |
JPH0611700B2 (ja) | アントラサイクリングリコシド含有薬学的組成物 | |
CN101795694B (zh) | 注射剂、注射液和注射用试剂盒制剂 | |
US11357728B2 (en) | Liposome having inner water phase containing sulfobutyl ether cyclodextrin salt | |
RU2110263C1 (ru) | Стерильный апирогенный раствор для инъекций противоопухолевого действия, содержащий физиологически приемлемую соль гликозида антрациклина | |
SK286421B6 (sk) | Prostriedok kahalalid F, súprava, rekonštituovanýa zriedený roztok s obsahom tohto prostriedku a použitie | |
DE60025494T2 (de) | Epothilon zusammensetzungen | |
US11903934B2 (en) | Rifabutin treatment methods, uses, and compositions | |
US11752165B2 (en) | Basic chemotherapeutic intratumour injection formulation | |
JP2001163776A (ja) | 安定化された液剤 | |
CN104940189B (zh) | 治疗增生病的组合物 | |
CN1374857A (zh) | 肠胃外用磷雌氮芥和磺烷基醚环化糊精制剂 | |
US6528524B2 (en) | Pharmaceutical compositions containing cinchonine dichlorhydrate | |
RU2662087C1 (ru) | Фармацевтическая композиция на основе соли производного оливомицина, обладающая противоопухолевой активностью | |
US20030225032A1 (en) | Pharmaceutical composition | |
JP2022548858A (ja) | リファブチンの処置方法、使用および組成物 | |
CN114191387A (zh) | 一种伏立康唑口服液的制备方法 | |
CN114668766A (zh) | 一种瑞马唑仑的药物组合物 | |
RU2245135C1 (ru) | Способ получения раствора метронидазола для инъекций | |
Vet—QL01XE06 | 708 Antineoplastics |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: DE Ref document number: 1142820 Country of ref document: HK |
|
C53 | Correction of patent of invention or patent application | ||
CB02 | Change of applicant information |
Address after: Tokyo, Japan, Japan Applicant after: Meiji Seika Pharma Co., Ltd. Address before: Tokyo, Japan, Japan Applicant before: Meiji Seika Kaisha, Ltd. |
|
COR | Change of bibliographic data |
Free format text: CORRECT: APPLICANT; FROM: MEIJI SEIKA KAISHA, LTD. (JP) TOKYO, JAPAN TO: MEIJI SEIKA PHARMA CO., LTD. |
|
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
REG | Reference to a national code |
Ref country code: HK Ref legal event code: GR Ref document number: 1142820 Country of ref document: HK |